UK details 2008-09 assistive medtech R&D activity
This article was originally published in Clinica
Executive Summary
The UK's Department of Health (DH) has published a comprehensive report on assistive medical technology R&D activity in 2008-09. The 105-page report details all projects carried out by, or on behalf of, any part of the government related to the development, introduction or evaluation of assistive technology; it also includes EU-funded projects. The report, published yesterday, is downloadable from the publications section of the DH website (www.dh.gov.uk).
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.